Literature DB >> 11060096

Detection of extended-spectrum beta-lactamases in klebsiellae with the Oxoid combination disk method.

M W Carter1, K J Oakton, M Warner, D M Livermore.   

Abstract

The Oxoid combination disk method for detecting extended-spectrum beta-lactamases (ESBLs) depends on comparing the inhibition zones of cefpodoxime (10-microg) and cefpodoxime-plus-clavulanate (10- plus 1-microg) disks. The presence of clavulanate enlarged the zones for all of 180 ESBL-producing klebsiellae by >/=5 mm, whereas zones for cefpodoxime-susceptible isolates and cefpodoxime-resistant isolates with AmpC and K1 beta-lactamases were enlarged by </=1 mm. Good discrimination was achieved with either the NCCLS or the British disk method.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11060096      PMCID： PMC87569     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  Detection of extended-spectrum beta-lactamases in members of the family enterobacteriaceae: comparison of the MAST DD test, the double disc and the Etest ESBL.

Authors:  F H M'Zali; A Chanawong; K G Kerr; D Birkenhead; P M Hawkey
Journal:  J Antimicrob Chemother       Date:  2000-06       Impact factor: 5.790

2.  Epidemiological typing of klebsiellae with extended-spectrum beta-lactamases from European intensive care units.

Authors:  M Yuan; H Aucken; L M Hall; T L Pitt; D M Livermore
Journal:  J Antimicrob Chemother       Date:  1998-05       Impact factor: 5.790

Review 3.  Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics.

Authors:  A A Medeiros
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

4.  Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactams.

Authors:  G S Babini; M Yuan; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

5.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

Authors:  V Jarlier; M H Nicolas; G Fournier; A Philippon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

6.  Bases of variation in resistance to beta-lactams in Klebsiella oxytoca isolates hyperproducing K1 beta-lactamase.

Authors:  R Gheorghiu; M Yuan; L M Hall; D M Livermore
Journal:  J Antimicrob Chemother       Date:  1997-10       Impact factor: 5.790

7.  Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.

Authors:  D M Livermore; M Yuan
Journal:  J Antimicrob Chemother       Date:  1996-09       Impact factor: 5.790

8.  Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test.

Authors:  C C Sanders; A L Barry; J A Washington; C Shubert; E S Moland; M M Traczewski; C Knapp; R Mulder
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

9.  Antimicrobial susceptibility testing for Klebsiella pneumoniae isolates resistant to extended-spectrum beta-lactam antibiotics.

Authors:  I S Jan; P R Hsueh; L J Teng; S W Ho; K T Luh
Journal:  J Formos Med Assoc       Date:  1998-10       Impact factor: 3.282

10.  Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae.

Authors:  C Brun-Buisson; P Legrand; A Philippon; F Montravers; M Ansquer; J Duval
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321
View more
  33 in total

Review 1.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Real-time PCR and melting curve analysis for reliable and rapid detection of SHV extended-spectrum beta-lactamases.

Authors:  C C Randegger; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Co-production of AmpC and extended spectrum beta-lactamases in cephalosporin-resistant Acinetobacter baumannii in Egypt.

Authors:  Heba Shehta Said; Abdalbagi Basheer Benmahmod; Ramadan Hassan Ibrahim
Journal:  World J Microbiol Biotechnol       Date:  2018-12-03       Impact factor: 3.312

Review 4.  Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact.

Authors:  Gerhard F Weldhagen; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

5.  Detection of extended-spectrum beta-lactamases in clinical isolates of Pseudomonas aeruginosa.

Authors:  Xiaofei Jiang; Zhe Zhang; Min Li; Danqiu Zhou; Feiyi Ruan; Yuan Lu
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

6.  Evaluation of an accelerated protocol for detection of extended-spectrum beta-lactamase-producing gram-negative bacilli from positive blood cultures.

Authors:  Shiri Navon-Venezia; Azita Leavitt; Ronen Ben-Ami; Yuval Aharoni; Mitchell J Schwaber; David Schwartz; Yehuda Carmeli
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

7.  Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates.

Authors:  Teresa Spanu; Maurizio Sanguinetti; Mario Tumbarello; Tiziana D'Inzeo; Barbara Fiori; Brunella Posteraro; Rosaria Santangelo; Roberto Cauda; Giovanni Fadda
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

8.  Comparison of nine phenotypic methods for detection of extended-spectrum beta-lactamase production by Enterobacteriaceae.

Authors:  Hélène Garrec; Laurence Drieux-Rouzet; Jean-Louis Golmard; Vincent Jarlier; Jérôme Robert
Journal:  J Clin Microbiol       Date:  2011-01-19       Impact factor: 5.948

9.  Evaluation of the current National Committee for Clinical Laboratory Standards guidelines for screening and confirming extended-spectrum beta-lactamase production in isolates of Escherichia coli and Klebsiella species from bacteremic patients.

Authors:  O T Katz; N Peled; P Yagupsky
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10-08       Impact factor: 3.267

Review 10.  The continuing challenge of ESBLs.

Authors:  Federico Perez; Andrea Endimiani; Kristine M Hujer; Robert A Bonomo
Journal:  Curr Opin Pharmacol       Date:  2007-09-17       Impact factor: 5.547
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.